Sonova Holding AG (SWX:SOON)
178.85
-0.15 (-0.08%)
Apr 1, 2026, 5:30 PM CET
Revenue
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Business Revenue | 1.83B | 1.82B | 1.70B | |||||||||||
Hearing Instruments Business Revenue Growth | 0.64% | 7.29% | -6.17% | |||||||||||
Audiological Care Business Revenue | 1.49B | 1.49B | 1.41B | |||||||||||
Audiological Care Business Revenue Growth | 0.38% | 5.46% | 3.88% | |||||||||||
Consumer Hearing Business Revenue | 232.60M | 252.50M | 239.70M | |||||||||||
Consumer Hearing Business Revenue Growth | -7.88% | 5.34% | -15.69% | |||||||||||
Total Hearing Instruments Segment Revenue | 3.56B | 3.56B | 3.35B | |||||||||||
Total Hearing Instruments Segment Revenue Growth | -0.07% | 6.38% | -3.00% | |||||||||||
Cochlear Implant Systems Revenue | 202.60M | 214.90M | 185.50M | |||||||||||
Cochlear Implant Systems Revenue Growth | -5.72% | 15.85% | 0.05% | |||||||||||
Upgrades and Accessories Revenue | 85.90M | 89.00M | 93.40M | |||||||||||
Upgrades and Accessories Revenue Growth | -3.48% | -4.71% | -7.98% | |||||||||||
Total Cochlear Implants Segment Revenue | 288.50M | 303.90M | 278.90M | |||||||||||
Total Cochlear Implants Segment Revenue Growth | -5.07% | 8.96% | -2.79% | |||||||||||
Revenue (Other) | 200.00K | 100.00K | 100.00K | |||||||||||
Revenue (Total) | 3.85B | 3.87B | 3.63B | |||||||||||
Revenue (Total) Growth | -0.46% | 6.58% | -2.98% |
Revenue by Geography
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Switzerland Revenue | - | 29.80M | 30.60M | |||||||||||
Switzerland Revenue Growth | - | -2.61% | -14.76% | |||||||||||
EMEA (excl. Switzerland) Revenue | - | 1.94B | 1.83B | |||||||||||
EMEA (excl. Switzerland) Revenue Growth | - | 6.29% | -0.21% | |||||||||||
USA Revenue | - | 1.16B | 1.07B | |||||||||||
USA Revenue Growth | - | 7.71% | -6.61% | |||||||||||
Americas (excl. USA) Revenue | - | 278.90M | 264.40M | |||||||||||
Americas (excl. USA) Revenue Growth | - | 5.48% | -3.50% | |||||||||||
Asia/Pacific Revenue | - | 456.40M | 429.40M | |||||||||||
Asia/Pacific Revenue Growth | - | 6.29% | -3.77% | |||||||||||
Revenue (Total) | 3.85B | 3.87B | 3.63B | |||||||||||
Revenue (Total) Growth | -0.46% | 6.58% | -2.98% |
EBITDA
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA) | 729.60M | 721.40M | 701.70M | |||||||||||
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth | 1.14% | 2.81% | -9.04% | |||||||||||
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA) | -700.00K | 28.40M | 25.40M | |||||||||||
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth | - | 11.81% | -15.62% | |||||||||||
Operating Income (Other) | -56.50M | -57.90M | -57.20M | |||||||||||
Operating Income (Total) | 672.40M | 691.90M | 669.90M | |||||||||||
Operating Income (Total) Growth | -2.82% | 3.28% | -10.29% |
Key Performance Indicators
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Business Growth in Local Currencies | 8.50% | 0.70% | |||||||||||
Audiological Care Business Growth in Local Currencies | 6.40% | 9.20% | |||||||||||
Consumer Hearing Business Growth in Local Currencies | 6.40% | -9.30% | |||||||||||
Total Hearing Instruments Segment Growth in Local Currencies | 7.50% | 3.20% | |||||||||||
Cochlear Implant Systems Growth in Local Currencies | 16.30% | 6.80% | |||||||||||
Upgrades and Accessories Growth in Local Currencies | -3.90% | -2.10% | |||||||||||
Total Cochlear Implants Segment Growth in Local Currencies | 9.50% | 3.60% |
Updated Sep 30, 2025. Data Source: Fiscal.ai.